Life sciences industry overview
The life sciences industry has played a pivotal role in tackling the impact of the COVID-19 crisis by developing the fastest novel vaccine in history. As a result, healthcare systems, governments, regulators, payers and providers, and nonprofit organizations are now looking for collaborative opportunities with life sciences companies. But within the life sciences industry, companies are challenged by the competitive pressures and constant fluctuations in market dynamics.
At Infiniti Research, we understand the current challenges facing the life sciences industry and provide customized solutions to monitor and quantify the global impact of the crisis, analyze the reimbursement environment, enhance market access and tendering strategies, track disease trends and therapeutic breakthroughs, and more. With market intelligence capabilities that span the entire spectrum of the life sciences industry, we help companies track shifts in customer preferences and make informed decisions that will help them achieve sustainability, improve operational efficiency, and increase profit margins. Our team comprises cross-functional domain experts and industry specialists who offer personalized life sciences market intelligence solutions to help our clients tackle challenges across all stages of drug development, including R&D, drug discovery, clinical trial progression, product commercialization, brand research, sales and marketing, generics and biosimilars, and managed care.
Want to learn more about how our global team of market research experts can help create new opportunities for your business? Let us know what you’re interested in, and we’ll put you on the right path.
Recent technological advances and a rise in the prevalence of diseases have set the ball rolling for the life sciences and biotechnology industry, providing a renewed platform to revive growth.
By adopting a unique combination of primary and secondary research and expert panel reviews, we help clients identify trends, opportunities and challenges impacting growth.
The rising demand for microbial applications in vaccine development is prompting businesses to devise futuristic strategies with life sciences market intelligence solutions.
We empower life sciences companies with balanced perspectives and expert insights on trends reshaping the business landscape.
Contact us to learn how we can help you.
Understanding Structural and Strategic Barriers to Entry in Global Markets
An existing market player might deliberately lower prices or take over a potential rival by purchasing sufficient shares to gain an edge in the market. As with other methods that further reinforce the barriers, regulators may prevent this to reduce competition.
Industry Best Practices for Manufacturing Companies
Manufacturing continues to evolve, opening up a whole new world of possibilities for progressive manufacturing companies with an eye on innovation. However, keeping up with the rapid transformations in the post-pandemic world presents a new...
Why Conducting Market Analysis is Crucial for Business Success
Starting a new business or developing a new product requires businesses to conduct an in-depth market analysis. Understanding market needs provides insights for developing and launching your product. Too often, businesses launch a new product...
Market Opportunity Analysis Helped an Industrial Heating Systems Manufacturer Build a Detailed Five-year Business Development Strategy
Explore our latest case study to understand how our market intelligence team’s market opportunity analysis aided an industrial heating systems manufacturer devise a robust five-year business growth strategy.
Agile Innovation in Healthcare: The New Business Imperative
Healthcare payers and providers face numerous challenges due to a dynamic business landscape. Thus, an organization’s ability to respond and adapt quickly to change has gained increased importance. Companies that have managed to crack the...
Value-based Healthcare Administration and the Rise of Medical Wearable Devices
Spiralling cost is admittedly a key issue for the healthcare sector, increasingly forcing the industry toward an outcome-based (value-based) delivery model in which money changes hands based on improved patient health outcomes and this applies to just about everyone’s paycheck: doctors, nurses, midwives, medical imaging facilities, radiologists, labs, hospitals, and urgent care clinics. With more data, comes new responsibilities. As intelligent medical devices start “talking” to each other, there is a risk of cybercriminals potentially hijacking patients’ personally identifiable information (PII) to commit fraud. The risk is very real, and robust security measures are certainly required to secure against damning data breaches. Moreover, the US Food & Drug Administration (FDA) holds medical device manufacturers responsible for identifying risks, including those related to cybersecurity, associated with their devices.